Groundbreaking deep-learning algorithm enhances prediction of postoperative mortality
In the United States, where more than 20 million surgeries occur annually, current …
Omada Health joins Amazon’s Health Condition Programs as launch partner
Omada Health, a virtual-first healthcare provider, announced a partnership with Amazon Health Services to increase awareness and discoverability of its cardiometabolic programs through Amazon’s new Health Condition Programs
Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3
Butterfly Network, Inc., a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.
Medable’s New Intelligent Automation Capabilities Cut Clinical Trial Technology Deployment Timelines By 50%
Medable Inc., the leading technology provider for modern clinical trials, announces new intelligent automation technology applied across its clinical trials platform to cut standard trial build timelines by at least half.
The global initiative MAIDA revolutionizes medical imaging data sharing for AI advancements
In a recent publication in The Lancet Digital Health, researchers Agustina Saenz, E…
Qvin’s Q-Pad: Revolutionizing Women’s Health through FDA-Cleared Menstrual Blood Testing
Qvin™, the biotechnology research company that developed the first and only healthc…
Apple Fitness+: exciting updates for 2024
Apple Fitness+, the tech giant's comprehensive fitness service, is gearing up for a…
Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management: SimpleSense-BP
Nanowear, a leader in healthcare-at-home remote diagnostics, announced that its nanotechnology-enabled wearable and software platform, SimpleSenseTM, has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-Medical Device (SaMD).
Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the publication of a new multi-domain model for capturing functional status in oncology through connected digital tools in Clinical & Translational Science.
Click Therapeutics and Boehringer Ingelheim Announce FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Negative Symptoms of Schizophrenia
NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital …